Percutaneous biliary drainage effectively lowers serum bilirubin to permit chemotherapy treatment

详细信息    查看全文

• 作者：Jennifer L. Levy ; Deepak Sudheendra ; Mandeep Dagli…
• 关键词：Bilirubin ; Biliary tract diseases ; Chemotherapy ; Cholangiocarcinoma ; Drainage ; Pancreatic neoplasms
• 刊名：Abdominal Imaging
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：41
• 期：2
• 页码：317-323
• 全文大小：651 KB
• 参考文献：1.King PD (2001) Hepatotoxicity of chemotherapy. Oncologist 6:162–176CrossRef PubMed
  2.Floyd J, Mirza I, Sachs B, Perry MC (2006) Hepatotoxicity of chemotherapy. Semin Oncol 33:50–67CrossRef PubMed
  3.Eklund JW, Trifilio S, Mulcahy MF (2005) Chemotherapy dosing in the setting of liver dysfunction. Oncology (Williston Park) 19:1057–1063
  4.Donelli MG, Zucchetti M, Munzone E, et al. (1998) Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer 34:33–46CrossRef PubMed
  5.Venook AP, Egorin MJ, Rosner GL, et al. (2000) Phase 1 and pharmacokinetic trial of gemcitabine in patients with hepatic and renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol 18:2780–2787PubMed
  6.Thornton RH, Ulrich R, Hsu M, et al. (2012) Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol 23:89–95CrossRef PubMed
  7.Adler DG, Baron TH, Davila RE, et al. (2005) ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 62:1–8CrossRef PubMed
  8.Weston BR, Ross WA, Wolff RA, et al. (2008) Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy. Cancer 112(11):2417–2423CrossRef PubMed
  9.Speer AR, Russell CG, Hatfield AW, et al. (1987) Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 330:57–62CrossRef
  10.Pinol V, Castellis A, Bordas JM, et al. (2002) Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225:27–34CrossRef PubMed
  11.Walter T, Ho CS, Horgan AM, et al. (2013) Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol 24:113–121CrossRef PubMed
  12.Guidi MA, Curvale C, Viscardi J, et al. (2015) Hilar bile duct tumors: endoscopic or percutaneous drainage? A prospective analysis. Rev Esp Enferm Dig 107:488–494CrossRef
  13.Mahgerefteh S, Hubert A, Klimov A, Bloom AI (2015) Clinical impact of percutaneous transhepatic insertion of metal biliary endoprostheses for palliation of jaundice and facilitation of chemotherapy. Am J Clin Oncol 38:489–494CrossRef PubMed
  14.Kwang MK, Park JW, Lee JK, et al. (2015) A comparison of preoperative biliary drainage methods for perihilar cholangiocarcinoma: endoscopic versus percutaneous transhepatic biliary drainage. Gut Liver 9(6):791CrossRef
  15.Saad W, Wallace MJ, Wojak JC, Kundu S, Cardella JF (2010) Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol 21:789–795CrossRef PubMed
  
• 作者单位：Jennifer L. Levy (1)
  Deepak Sudheendra (1)
  Mandeep Dagli (1)
  Jeffrey I. Mondschein (1)
  S. William Stavropoulos (1)
  Richard D. Shlansky-Goldberg (1)
  Scott O. Trerotola (1)
  Ursina Teitelbaum (2)
  Rosemarie Mick (3)
  Michael C. Soulen (1) (4)
  
  1. Division of Interventional Radiology, University of Pennsylvania, Philadelphia, PA, USA
  2. Division of Gastrointestinal Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
  3. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  4. Department of Radiology, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA, 19104, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Gastroenterology
  Hepatology
  
• 出版者：Springer New York
• ISSN：1432-0509

文摘

Purpose For digestive tract cancers, the bilirubin threshold for administration of systemic chemotherapy can be 5 or 2 mg/dL (85.5 or 34.2 μmol/L) depending upon the regimen. We examined the ability of percutaneous biliary drainage (PBD) in patients with malignant biliary obstruction to achieve these clinically relevant endpoints.